+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vulvodynia"

Vulvodynia Treatment Global Market Report 2024 - Product Thumbnail Image

Vulvodynia Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Vulvodynia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Vulvodynia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Vulvodynia is a chronic condition that affects the vulva, the external female genitalia. It is characterized by pain, burning, stinging, and itching in the vulvar area. Symptoms can range from mild to severe and can last for months or even years. The cause of vulvodynia is unknown, but it is believed to be related to nerve damage, hormonal imbalances, or an underlying medical condition. Treatment options include medications, physical therapy, lifestyle changes, and surgery. The Vulvodynia market is an important part of Women's Health, as it affects millions of women worldwide. It is estimated that up to 16% of women experience vulvodynia at some point in their lives. Despite its prevalence, there is still a lack of awareness and understanding of the condition, which can lead to delays in diagnosis and treatment. Companies in the Vulvodynia market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples include Allergan, Pfizer, and Johnson & Johnson, as well as medical device companies such as Boston Scientific and Medtronic. Additionally, healthcare providers such as hospitals, clinics, and private practices offer treatments for vulvodynia. Show Less Read more